XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Collaboration revenues   $ 55,180
Total revenues   55,180
Operating expenses:    
Research and development $ (2,506,906) (2,791,205)
General and administrative (1,870,794) (2,493,759)
Total operating expenses (4,377,700) (5,284,964)
Loss from operations (4,377,700) (5,229,784)
Other income/(expense):    
Interest income, net 115,303 152,035
Foreign exchange gain/(loss), net 268,077 (42,842)
Loss before income tax (3,994,320) (5,120,591)
Income tax (19,874) (16,728)
Net loss $ (4,014,194) $ (5,137,319)
Net loss per shares:    
Net loss per share attributable to common stockholders - Basic $ (0.22) $ (0.43)
Net loss per share attributable to common stockholders - Diluted $ (0.22) $ (0.43)
Weighted average common shares - Basic 17,978,951 11,935,081
Weighted average common shares - Diluted 17,978,951 11,935,081